Skip to content

Effects of In-Home Addiction Treatment for First Responders

Effects of an In-Home Treatment Program for First Responders With Substance Use Disorder: A Retrospective Analysis

Status
Suspended
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03907709
Enrollment
15
Registered
2019-04-09
Start date
2019-04-08
Completion date
2020-07-28
Last updated
2019-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance Use Disorders

Brief summary

Retrospective analysis to evaluate impact of an in-home addiction treatment program on first responders with substance use disorder.

Detailed description

The purpose of this retrospective study is to evaluate the effects of in-home addiction treatment on first responders with substance use disorder. Treatment engagement, hospitalizations, detox and residential addiction treatment admissions, and lethal overdoses will be measured. Although not the primary focus, recidivism and relapse will be measured.

Interventions

BEHAVIORALIn-Home Addiction Treatment Program

* Treatment was delivered per treatment protocol * Primary IHAT Care Team consisted of a licensed Care Coordinator (LPN, RN, MSW, LPC, or LMFT) and two Recovery Advisors * Urine drug screens administered randomly * Appointments were scheduled per protocol for 52 weeks * Within first two weeks of care, all clients are provided an evaluation by a psychiatrist to ensure fitness for program

Sponsors

In-Home Addiction Treatment Institute, Inc.
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years

Inclusion criteria

* Client is or has been a first responder * Client enrolled in Aware Recovery Care after April 2017 * Client discharged from Aware Recovery Care before March 2019 * Client has primary substance use disorder diagnosis

Exclusion criteria

* Client has never been first responder * Client moved out of service area or lost insurance during care

Design outcomes

Primary

MeasureTime frameDescription
Rate of Retention in TreatmentMeasured throughout 365 day duration of anticipated length of stayParticipation in In-Home Addiction Treatment Program using length of stay reports
Brief Addiction Monitor questionnaireConducted monthly throughout 365 day anticipated length of stay in programMeasure change in client report of symptoms related to substance use disorder
Positive Outcomes Measures SurveyCompleted at week 3 or 4, Week 30, Week 35, Week 44, and Week 50 throughout 52 week anticipated length of program participationMeasures changes in quality of life using client self-report inquiring about employment, connection to care team, community engagement using yes/no/not applicable response scale

Secondary

MeasureTime frameDescription
Relapse ratesRandomly administered throughout 365 day anticipated length of program participationOccurrence of substance use measured through urine drug screening and breathalyzer tests
HospitalizationMeasured throughout 365 day anticipated length of program participationOccurrence of Emergency Room and Inpatient hospital admissions
Detox and Residential AdmissionsMeasured throughout 365 day anticipated length of program participationOccurrence of residential treatment and detox admission

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026